Immunoprecise Current Assets vs Trade and Non Trade Payables Analysis

IPA
 Stock
  

USD 4.11  0.07  1.73%   

Immunoprecise Antibodies financial indicator trend analysis is infinitely more than just investigating Immunoprecise Antibodies recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Immunoprecise Antibodies is a good investment. Please check the relationship between Immunoprecise Antibodies Current Assets and its Trade and Non Trade Payables accounts. Please see Risk vs Return Analysis.

Current Assets vs Trade and Non Trade Payables

Current Assets vs Trade and Non Trade Payables Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Immunoprecise Antibodies Current Assets account and Trade and Non Trade Payables. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Immunoprecise Antibodies' Current Assets and Trade and Non Trade Payables is 0.86. Overlapping area represents the amount of variation of Current Assets that can explain the historical movement of Trade and Non Trade Payables in the same time period over historical financial statements of Immunoprecise Antibodies, assuming nothing else is changed. The correlation between historical values of Immunoprecise Antibodies' Current Assets and Trade and Non Trade Payables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Assets of Immunoprecise Antibodies are associated (or correlated) with its Trade and Non Trade Payables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Trade and Non Trade Payables has no effect on the direction of Current Assets i.e., Immunoprecise Antibodies' Current Assets and Trade and Non Trade Payables go up and down completely randomly.

Correlation Coefficient

0.86
Relationship DirectionPositive 
Relationship StrengthStrong

Current Assets

Current assets of Immunoprecise Antibodies include cash, cash equivalents, short-term investments, accounts receivable, stock inventory and the portion of prepaid liabilities which will be paid within a year. Depending on the nature of the business, current assets can range from barrels of crude oil, to baked goods, to foreign currency. Current assets are important because they are the assets that are used to fund day-to-day operations of Immunoprecise Antibodies. The current portion of Total Assets; reported if a company operates a classified balance sheet that segments current and non-current assets.

Trade and Non Trade Payables

A component of Total Liabilities representing trade and non-trade payables.
Most indicators from Immunoprecise Antibodies fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Immunoprecise Antibodies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Please see Risk vs Return Analysis.Immunoprecise Antibodies Selling General and Administrative Expense is projected to increase significantly based on the last few years of reporting. The past year's Selling General and Administrative Expense was at 8.53 Million. The current year Issuance Purchase of Equity Shares is expected to grow to about 4 M, whereas Net Cash Flow Business Acquisitions and Disposals is forecasted to decline to (3.8 M).
 2019 2020 2021 2022 (projected)
Interest Expense537 K517 K334 K365.43 K
Gross Profit8.03 M11.54 M10.98 M10.97 M

Immunoprecise Antibodies fundamental ratios Correlations

0.910.870.9-0.25-0.730.320.51.00.841.00.890.890.850.620.920.990.820.70.830.87
0.910.591.0-0.08-0.950.60.510.940.540.880.740.740.570.270.690.860.890.750.980.62
0.870.590.56-0.39-0.31-0.090.370.841.00.910.860.860.980.90.980.920.550.470.440.97
0.91.00.56-0.11-0.960.590.470.920.520.860.70.70.530.220.660.840.870.720.990.59
-0.25-0.08-0.39-0.11-0.050.710.68-0.25-0.44-0.250.080.08-0.22-0.21-0.21-0.240.320.510.01-0.41
-0.73-0.95-0.31-0.96-0.05-0.74-0.46-0.77-0.25-0.68-0.53-0.53-0.290.04-0.43-0.65-0.84-0.7-0.99-0.35
0.320.6-0.090.590.71-0.740.730.35-0.160.270.380.380.0-0.230.110.260.770.790.69-0.09
0.50.510.370.470.68-0.460.730.490.320.520.780.780.530.430.550.530.850.950.510.38
1.00.940.840.92-0.25-0.770.350.490.80.990.870.870.810.570.890.980.830.70.860.84
0.840.541.00.52-0.44-0.25-0.160.320.80.880.820.820.970.90.960.890.480.410.390.97
1.00.880.910.86-0.25-0.680.270.520.990.880.920.920.890.690.951.00.810.70.780.91
0.890.740.860.70.08-0.530.380.780.870.820.921.00.920.790.950.930.860.850.650.86
0.890.740.860.70.08-0.530.380.780.870.820.921.00.920.790.950.930.860.850.650.86
0.850.570.980.53-0.22-0.290.00.530.810.970.890.920.920.940.990.910.620.590.430.96
0.620.270.90.22-0.210.04-0.230.430.570.90.690.790.790.940.870.710.370.40.120.89
0.920.690.980.66-0.21-0.430.110.550.890.960.950.950.950.990.870.960.70.650.560.96
0.990.860.920.84-0.24-0.650.260.530.980.891.00.930.930.910.710.960.80.70.760.91
0.820.890.550.870.32-0.840.770.850.830.480.810.860.860.620.370.70.80.970.880.57
0.70.750.470.720.51-0.70.790.950.70.410.70.850.850.590.40.650.70.970.750.49
0.830.980.440.990.01-0.990.690.510.860.390.780.650.650.430.120.560.760.880.750.49
0.870.620.970.59-0.41-0.35-0.090.380.840.970.910.860.860.960.890.960.910.570.490.49
Click cells to compare fundamentals

Immunoprecise Antibodies Account Relationship Matchups

Be your own money manager

Our tools can tell you how much better you can do entering a position in Immunoprecise Antibodies without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Money Managers Now

   

Money Managers

Screen money managers from public funds and ETFs managed around the world
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Immunoprecise Antibodies using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Risk vs Return Analysis. Note that the Immunoprecise Antibodies information on this page should be used as a complementary analysis to other Immunoprecise Antibodies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Complementary Tools for Immunoprecise Stock analysis

When running Immunoprecise Antibodies price analysis, check to measure Immunoprecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunoprecise Antibodies is operating at the current time. Most of Immunoprecise Antibodies' value examination focuses on studying past and present price action to predict the probability of Immunoprecise Antibodies' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immunoprecise Antibodies' price. Additionally, you may evaluate how the addition of Immunoprecise Antibodies to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Is Immunoprecise Antibodies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunoprecise Antibodies. If investors know Immunoprecise will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunoprecise Antibodies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
101.1 M
Quarterly Revenue Growth YOY
0.074
Return On Assets
-0.13
Return On Equity
-0.25
The market value of Immunoprecise Antibodies is measured differently than its book value, which is the value of Immunoprecise that is recorded on the company's balance sheet. Investors also form their own opinion of Immunoprecise Antibodies' value that differs from its market value or its book value, called intrinsic value, which is Immunoprecise Antibodies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunoprecise Antibodies' market value can be influenced by many factors that don't directly affect Immunoprecise Antibodies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunoprecise Antibodies' value and its price as these two are different measures arrived at by different means. Investors typically determine Immunoprecise Antibodies value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunoprecise Antibodies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.